Agenus Inc. (AGEN) États Financiers et Données Historiques

Agenus Inc. (AGEN) — Prix $7.22 HealthcareBiotechnology — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Agenus Inc. (AGEN): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Agenus Inc. a enregistré un chiffre d'affaires de $114.2M sur le dernier exercice, avec un CAGR sur 5 ans de 5.3%.

Marges des 12 derniers mois: marge brute 75.6%, marge opérationnelle 27.3%, marge nette 69.3%.

Au prix actuel de $7.22, AGEN se négocie à un PER de 2.68 et un ROE de -38.12%. La capitalisation boursière s'établit à $301M.

Compte de Résultat (10 ans)

Année2016201720182019202020212022202320242025
Revenus$22.6M$42.9M$36.8M$150.0M$88.2M$295.7M$98.0M$156.3M$103.5M$114.2M
Coût des Ventes$95.0M$116.1M$124.6M$168.3M$145.0M$182.1M$197.3M$237.7M$156.0M$80.4M
Marge Brute-$72.4M-$73.2M-$87.8M-$18.3M-$56.8M$113.6M-$99.2M-$81.4M-$52.6M$33.8M
R&D$95.0M$116.1M$124.6M$168.3M$142.6M$178.6M0$234.6M$155.5M0
Frais Généraux$33.1M$33.7M$37.3M$46.0M$59.2M$76.4M$81.0M$78.7M$71.9M$54.4M
Charges Opérationnelles$33.1M$33.7M$37.3M$51.8M$60.4M$87.8M$80.2M$78.2M$67.9M$54.4M
Résultat Opérationnel-$107.5M-$103.8M-$123.8M-$70.1M-$117.2M$25.7M-$179.4M-$159.5M-$120.5M-$20.6M
EBITDA-$104.7M-$95.8M-$130.5M-$63.4M-$114.6M$43.8M-$161.8M-$145.9M-$101.3M$62.2M
Charges d'Intérêt$17.3M$18.9M$25.3M$41.5M$61.1M$65.7M$61.9M$97.9M$117.6M$55.3M
Résultat Avant Impôts-$127.0M-$120.7M-$162.0M-$111.6M-$182.9M-$28.7M-$230.7M-$257.4M-$232.3M-$3.1M
Impôts-$3.0M0-$12.9M0000000
Résultat Net-$127.0M-$120.7M-$159.7M-$107.7M-$180.9M-$23.9M-$220.1M-$245.8M-$227.2M$115000
BPA$-29.17$-24.53$-28.83$-22.10$-21.00$-2.11$-15.64$-13.75$-10.59$-0.00
BPA Dilué$-29.17$-24.53$-28.83$-22.10$-21.00$-2.11$-15.64$-13.75$-10.59$-0.00
Actions en Circulation (Diluées)$4.4M$4.9M$5.5M$6.7M$8.6M$11.4M$14.1M$17.9M$21.5M$29.7M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$30.2M$34.2M$33.7M$34.5M
Marge Brute$6.0M$26.7M$33.2M$34.5M
Résultat Opérationnel-$4.5M$14.4M$15.1M$11.3M
EBITDA$80.1M$6.0M$54.5M$15.2M
Résultat Net$63.9M-$10.6M$39.2M-$550000
BPA$2.00$-0.30$1.03$-0.01
BPA Dilué$1.94$-0.30$1.02$-0.01

Bilan (10 ans)

Année2016201720182019202020212022202320242025
Trésorerie$76.4M$60.2M$53.1M$61.8M$99.9M$291.9M$178.7M$76.1M$40.4M$3.0M
Placements à Court Terme00000$15.0M$14.7M000
Créances$11.4M$1.1M$938141$16.3M$1.2M$1.5M$2.7M$25.8M$407000$1.8M
Stocks$88200$79491$55491$7.4M0$20.4M$13.8M000
Actifs Courants$91.3M$73.6M$74.8M$86.5M$113.8M$332.0M$213.1M$112.4M$45.6M$133.4M
Immobilisations Corporelles$25.6M$26.2M$25.1M$33.7M$60.3M$91.1M$164.3M$163.0M$147.4M$24.2M
Goodwill$22.4M$23.0M$22.9M$23.2M$25.5M$24.9M$25.5M$24.7M$24.1M$24.1M
Actifs Incorporels$16.4M$31.8M$12.3M$10.5M$10.9M$8.5M$6.2M$4.4M$3.4M$3.0M
Actifs Totaux$157.0M$138.4M$136.4M$155.3M$214.5M$466.0M$413.6M$313.9M$226.3M$226.8M
Dettes Fournisseurs$5.4M$8.1M$13.6M$13.6M$17.0M$30.5M$40.9M$61.4M$61.5M$83.0M
Dette à Court Terme$146061$20.6M$146000$646000$833000$728000$575000$146000$2.7M$155.1M
Passifs Courants$40.9M$56.4M$68.1M$122.2M$129.9M$156.9M$189.0M$255.9M$221.4M$323.5M
Dette à Long Terme$130.5M$142.4M$13.21B$13.4M$18.9M$12.8M$12.6M$12.8M$30.5M$169.7M
Passifs Totaux$196.1M$214.2M$310.9M$386.7M$426.0M$418.0M$468.5M$462.3M$532.7M$504.7M
Réserves-$905.3M-$1.03B-$1.18B-$1.28B-$1.47B-$1.49B-$1.71B-$1.96B-$2.18B-$2.18B
Capitaux Propres-$39.1M-$75.8M-$172.5M-$225.4M-$203.7M$34.4M-$61.3M-$160.3M-$326.4M-$271.1M
Dette Totale$130.7M$163.0M$13.4M$23.4M$55.7M$58.3M$78.4M$93.2M$94.9M$334.9M
Dette Nette$54.3M$102.8M-$39.7M-$38.4M-$44.1M-$248.6M-$114.9M$17.1M$54.4M$331.9M
Fonds de Roulement$50.5M$17.1M$6.7M-$35.7M-$16.1M$175.0M$24.2M-$143.5M-$175.8M-$190.1M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$3.5M$3.0M$35.0M$18.7M
Actifs Totaux$233.9M$226.8M$186.5M$172.7M
Passifs Totaux$514.8M$504.7M$414.4M$378.5M
Capitaux Propres-$274.1M-$271.1M-$221.2M-$199.1M
Dette Totale$45.8M$334.9M$304.5M$40.7M

Tableau de Flux (10 ans)

Année2016201720182019202020212022202320242025
Résultat Net-$127.0M-$120.7M-$162.0M-$111.6M-$182.9M-$28.7M-$230.7M-$257.4M-$232.3M-$232.3M
Amortissements$4.9M$6.0M$6.3M$6.7M$7.2M$6.8M$6.9M$13.6M$13.3M$13.3M
Stock-based Compensation$13.2M$12.4M$7.6M$9.9M$10.4M$19.6M$18.3M$22.9M$17.4M$17.4M
Variation du BFR$10.4M-$6.5M$170051$58.7M$9.0M-$9.7M$24.1M$10.8M$32.6M$27.3M
Cash Flow Opérationnel-$80.0M-$94.2M-$131.1M-$18.7M-$139.1M$10.1M-$175.4M-$224.2M-$158.3M-$158.3M
CapEx-$12.5M-$3.1M-$3.6M-$4.7M-$3.5M-$33.8M-$53.1M-$10.0M-$576000-$576000
Acquisitions0$120000$61870-$9750000-$2.9M000
Rachat d'Actions-$667050-$527000000-$1.7M-$3.8M-$5.2M0-$87000
Dividendes Payés0000000000
Free Cash Flow-$92.5M-$97.3M-$134.7M-$23.3M-$142.6M-$23.7M-$228.4M-$234.2M-$158.9M-$158.9M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$14.7M-$16.6M-$36.0M-$31.2M
CapEx0000
Free Cash Flow-$14.7M-$16.6M-$36.0M-$31.2M
Dividendes Payés0000
Stock-based Compensation$3.2M$3.5M0$3.6M

Croissance et Marges (10 ans)

Année2016201720182019202020212022202320242025
Croissance Revenus (annuelle)+89.9%-14.2%+307.9%-41.2%+235.3%-66.8%+59.5%-33.8%+10.4%
Croissance Résultat Net (annuelle)+5.0%-32.3%+32.6%-68.0%+86.8%-819.8%-11.7%+7.5%+100.1%
Croissance BPA (annuelle)+15.9%-17.5%+23.3%+5.0%+90.0%-641.2%+12.1%+23.0%+100.0%
Variation Actions (annuelle)+13.0%+12.6%+21.9%+27.8%+32.7%+23.1%+27.0%+20.0%+38.5%
Croissance FCF (annuelle)-5.3%-38.4%+82.7%-510.8%+83.4%-865.1%-2.5%+32.1%+0.0%
Marge Brute-320.7%-170.8%-238.7%-12.2%-64.4%38.4%-101.2%-52.1%-50.8%29.6%
Marge Opérationnelle-476.1%-242.1%-336.6%-46.7%-133.0%8.7%-183.0%-102.1%-116.4%-18.0%
Marge EBITDA-464.0%-223.5%-354.7%-42.3%-130.0%14.8%-165.1%-93.4%-97.9%54.5%
Marge Nette-562.6%-281.5%-434.1%-71.7%-205.2%-8.1%-224.5%-157.2%-219.6%0.1%
Marge FCF-409.7%-227.0%-366.2%-15.6%-161.7%-8.0%-233.0%-149.8%-153.6%-139.1%
Taux d'Imposition Effectif2.4%-0.0%8.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Données par Action (10 ans)

Année2016201720182019202020212022202320242025
FCF par Action$-21.24$-19.78$-24.32$-3.46$-16.53$-2.07$-16.22$-13.09$-7.40$-5.34
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$4.4M$4.9M$5.5M$6.7M$8.6M$11.4M$14.1M$17.9M$21.5M$29.7M

Quoi regarder en Biotech

La plupart des petites biotechs perdent de l'argent. Les analyser avec le P/E n'a aucun sens — regardez cash et pipeline.

Rentabilité

Rentabilité des capitaux propres-38.12%
Rentabilité du capital investi-129.48%
Rentabilité des actifs53.28%
Marge brute75.63%
Marge opérationnelle27.28%
Marge nette69.34%

Santé financière

Dette / Capitaux propres-0.20
Ratio de liquidité0.34

Ratios Clés (10 ans)

Année2016201720182019202020212022202320242025
PER-2.82-2.66-1.65-3.68-3.03-30.52-3.07-1.20-0.26-923.53
P/B-9.17-4.23-1.53-2.44-2.6921.40-11.03-1.85-0.18-0.34
P/V15.897.487.173.666.222.496.901.900.570.82
Marge Brute-320.7%-170.8%-238.7%-12.2%-64.4%38.4%-101.2%-52.1%-50.8%29.6%
Marge Opérationnelle-476.1%-242.1%-336.6%-46.7%-133.0%8.7%-183.0%-102.1%-116.4%-18.0%
Marge Nette-562.6%-281.5%-434.1%-71.7%-205.2%-8.1%-224.5%-157.2%-219.6%0.1%

Entreprises liées: ABOS · FATE · HURA · INO · IRD · PLRX · SEER

Explorer le secteur: Healthcare · Biotechnology

Plus de sections de AGEN: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions